Recombinant IL13 (Lebrikizumab Biosimilar) antibody

Catalog No. ABIN7829211

The Humanized Monoclonal anti-IL13 (Lebrikizumab Biosimilar) antibody (ABIN7829211) specifically detects IL13 (Lebrikizumab Biosimilar). The antibody is reactive with Human samples.

Quick Overview for Recombinant IL13 (Lebrikizumab Biosimilar) antibody (ABIN7829211)

Target: IL13 (Lebrikizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This IL13 (Lebrikizumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-IL13 (Lebrikizumab Biosimilar) Antibody

Purpose: Anti-IL13(lebrikizumab biosimilar) mAb

Isotype: IgG4

Application Details

Comment:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Please see Certificate of Analysis for specific instructions of reconstitution.

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Expiry Date: 12 months

Target Details for IL13 (Lebrikizumab Biosimilar)

Target: IL13 (Lebrikizumab Biosimilar)

Alternative Name: Lebrikizumab Biosimilar

Target Type: Biosimilar

Background: Synonyms Target:P600,IL-13,NC30
Synonyms Antibody:DRM 06,DRM-06,DRM06,DRM 6,DRM-6,DRM6,LY 3650150,LY-3650150,LY3650150,MILR1444A,MILR-1444A,MILR 1444,ARG 3637,ARG-3637,ARG3637,RO 5490255,RO-5490255,RO5490255,TNX 650,TNX-650,TXN650

UniProt: P35225